INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 133 filers reported holding INTRA CELLULAR THERAPIES INC in Q4 2017. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,793,000 | -62.9% | 38,536 | -54.5% | 0.01% | -60.9% |
| Q2 2022 | $4,836,000 | -25.2% | 84,720 | -19.9% | 0.02% | +9.5% |
| Q1 2022 | $6,469,000 | +1947.2% | 105,728 | +428.6% | 0.02% | +2000.0% |
| Q3 2017 | $316,000 | +96.3% | 20,000 | +53.8% | 0.00% | 0.0% |
| Q2 2017 | $161,000 | -20.3% | 13,000 | +150.0% | 0.00% | 0.0% |
| Q2 2016 | $202,000 | -24.6% | 5,200 | -22.4% | 0.00% | 0.0% |
| Q3 2015 | $268,000 | -74.2% | 6,700 | -79.4% | 0.00% | -80.0% |
| Q2 2015 | $1,037,000 | -73.6% | 32,450 | -80.3% | 0.01% | -72.2% |
| Q1 2015 | $3,935,000 | – | 164,797 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 675,000 | $26,203,000 | 7.44% |
| EcoR1 Capital, LLC | 244,950 | $9,509,000 | 3.75% |
| Redmile Group, LLC | 971,565 | $37,716,000 | 3.60% |
| Ghost Tree Capital, LLC | 120,000 | $4,658,000 | 1.34% |
| SENZAR ASSET MANAGEMENT, LLC | 144,624 | $5,614,304,000 | 1.22% |
| GREAT POINT PARTNERS LLC | 100,000 | $3,882,000 | 1.11% |
| BB BIOTECH AG | 700,000 | $27,174,000 | 1.07% |
| Rhenman & Partners Asset Management AB | 115,000 | $4,464,000 | 0.79% |
| Lisanti Capital Growth, LLC | 12,260 | $476,000 | 0.72% |
| Rock Springs Capital Management LP | 190,000 | $7,376,000 | 0.55% |